During herpes simplex virus type 1 (HSV-1) latent infection in human dorsal root ganglia, limited viral transcription, which has been linked to HSV-1 reactivation ability, takes place. To study the involvement of this transcription in HSV-1 replication in neuronal cells and consequently in viral latency, we constructed stably transfected neuronal cell lines containing (i) the entire HSV-1 latency transcriptionally active DNA fragment, (ii) the same DNA sequence with deletions of the latency-associated transcript (LAT) promoters, or (iii) the DNA coding sequence of the LAT domain. Replication of HSV-1 or a LAT-negative mutant was markedly repressed in the LAT-expressing cells, a phenomenon mediated by the LATs. To study the mechanism responsible for this effect, we examined LAT influence upon expression of HSV-1 immediate-early (IE) genes ICP0, ICP4, and ICP27, by Northern blot analysis. Following infection of a LAT-expressing neuronal cell line with a LAT-negative mutant, the steady-state levels of all three IE mRNAs were reduced compared to those for control cells. Transient transfections into a neuronal cell line indicated that the LAT suppressive effect upon ICP0 mRNA was mediated directly and was not due to the LAT effect upon the ICP0 promoter. We therefore propose that the LATs may repress viral replication in neuronal cells by reducing IE gene mRNA levels and thus facilitate the establishment of HSV-1 latency in nervous tissue.
p⌬prLAT (Fig. 1D ) was derived from pLAT/ICP0 by two deletions that removed the CMV IE promoter and the latency-associated promoter 2 (LAP2 [21] ) and therefore is incapable of expressing HSV-1 LATs or mLAT but contains the ICP0, ␥34.5, ORF P, and ORF O genes. pLAT/ICP0 was cleaved with HindIII and NdeI enzymes to delete the CMV promoter sequence (500 bp). The 14.4-kb vector with a deletion of the promoter was subjected to Klenow fragment (Promega) activity for a filling-in reaction, followed by ligation by T4 ligase (Promega). This vector was then cleaved with BstEII enzyme at nucleotides 119194 and 120091 to delete the LAP2 promoter (897 bp). The 13.5-kb DNA fragment was subjected to ligation reaction to obtain the p⌬prLAT vector.
pLAT (Fig. 1E ) was derived from pLAT/ICP0 by deletion of the sequences downstream from the 3Ј end of the LAT gene; therefore, it is capable of expressing only the LATs. pLAT/ICP0 was cleaved with restriction enzyme MluI at nucleotide 121651 and with BamHI at nucleotides 123459 and 129259. This yielded three DNA fragments, 1.8, 5.8, and 7.3 kb. The 7.3-kb fragment, which contains only the LAT coding sequence, was subjected to Klenow fragment filling-in reaction, followed by ligation by T4 ligase.
Cell lines and viruses. NA cells (39), a subclone of neuro-2a, a clonal line of C-1300 mouse neuroblastoma cells (1), were kindly provided by A. McMorris, The Wistar Institute, Philadelphia, Pa. Cells were maintained in minimal essential Eagle medium (MEEM) with 10% heat-inactivated fetal calf serum (FCS). CV-1 cells were maintained in Dulbecco's modified Eagle's medium with 10% FCS. HSV-1 strain F was obtained from B. Roizman, University of Chicago, Chicago, Ill. FS1001K, a KOS strain-derived LAT-negative mutant (15) , was kindly provided by N. Fraser, The Wistar Institute. The viruses were propagated and their titers were determined on CV-1 cells, and results are represented as PFU per milliliter.
Cell transfections. Transient transfections were performed according to the method of Cullen (14) and as detailed before (37). Cells were harvested for RNA extraction 48 h posttransfection. Stable transfections were performed as described by us before (22). pSV 2 neo, a plasmid containing the neomycin resistance gene, was used for clonal selection.
Isolation of RNA and Northern blot analysis. Total RNA was extracted from cells with Tri reagent (Molecular Research Center, Inc.) according to the manufacturer's instructions. For reverse transcription-PCR (RT-PCR), RNAs were treated with 5 U of RQ1 DNase (Promega), extracted with phenol-chloroform and chloroform, and precipitated in ethanol. Northern blot analysis was performed according to the method of Spivack and Fraser (56) . RNA markers (281 to 6,583 bases) were purchased from Promega. Computerized image analysis and quantitation were performed by a Bio-Imaging analyzer (Fuji Corp.) (68) .
PCR amplification of reverse-transcribed RNA. RT-PCR was performed as described by us before (37). The following oligonucleotide primers that flank the intron within the 2.0-kb LAT (Fig. 1F) were prepared according to the published sequence of HSV-1 (45): P2, 5Ј-GACTCTGTTACTTACCCGTCCGAC-3Ј (HSV-1 bases 119612 to 119635), and P3, 5Ј-GAAAGCATCCTGCCACTGGC ATGGA-3Ј (bases 120426 to 120402). RT was performed with primer P3.
For RT-PCR analysis of the HSV-1 ICP0 gene, the following primers that flank the first 5Ј intron within the gene (Fig. 1F) were used: P11, 5Ј-TCTCGA ACAGTTCCGTGTCCGT-3Ј (bases 123130 to 123151), and P10, 5Ј-TCTCCG CATCACCACAGAAG-3Ј (bases 124192 to 124173). RT was performed with primer P11.
For PCR analysis of the ICP27 gene, the following primers were used ( Fig.  1B) : P12, 5Ј-CCCTTTCTCCAGTGCTACCTGAA-3Ј (bases 114919 to 114941), and P13, 5Ј-GTGCGTGTCTAGGATTTCGATC-3Ј (bases 115170 to 115149).
For RT-PCR analysis of the mouse CuZn superoxide dismutase (CuZn SOD) gene (2), the following primers were used: P14, 5Ј-GAAAGCGGTGTGCGTG CTGAAG-3Ј (SOD exon 1), and P15, 5Ј-GAGTGAGGATTAAAATGAGGTC C-3Ј (SOD exon 3). RT was performed with primer P15.
The primers were chosen according to the following criteria: (i) GC content of the primer of not less than 50%, (ii) absence of significant homology with all rodent and human sequences present in the GenBank database or with other HSV-1 sequences, (iii) size of the PCR product of between 0.2 and 1 kb, and (iv) avoidance of sequences which contain polypurine or polypyrimidine base repetition.
Southern blot analysis. DNA fragments were resolved by 1.5% agarose gel electrophoresis and transferred onto a GeneScreen Plus membrane (New Research Products), by the salt transfer protocol of the manufacturer. Hybridization and washes were also performed according to the manufacturer's instructions. The filters were autoradiographed with XAR-5 film at Ϫ70°C with intensifying screens (Du Pont).
Preparation of radioactively labeled DNA probes. The DNA fragments that served as probes for the LATs and ICP0 and ICP4 mRNAs were cleaved from the vector pLAT/ICP0 and purified from an agarose gel. We used the following DNA fragments (Fig. 1B) : a BstEII-BamHI probe, covering the HSV-1 genomic region from bp 121068 to 123463; a BstEII-BstEII probe consisting of two equimolar fragments, 897 and 977 bp, covering the genomic sequence from bp 119194 to 121068; and an AflIII-BamHI probe covering the genomic sequence from bp 128059 to 129259.
The 251-bp probe for the ICP27 gene was prepared by PCR of BamHI DNA fragment B (47) with primers P12 and P13.
A 198-bp DNA probe for the housekeeping CuZn SOD gene (2) was prepared by RT-PCR of RNA from TG of mice with primers P14 and P15.
All probes were labeled with [␣-32 P]dCTP by random priming with the Multiprime DNA labeling system of Amersham. Specific activities of the probes were approximately 10 8 cpm/g of DNA. For preparation of the single-stranded DNA probe for ICP0 mRNA, the following primers were used ( Fig. 1F ): P11 (described above) and P9, 5Ј-TGG TGTTGGTGTTACTGCTG-3Ј (bases 122310 to 122330). Primers were 5Ј end labeled with [␥-32 P]dATP followed by PCR with the Taq DNA polymerase (sequencing grade; Promega) according to the instructions in the manual. The PCR was performed in the presence of dATP, dGTP, and dTTP (Boehringer) (1.6 mM each); 0.7 mM [␣-32 P]dCTP; 100 ng of the BstEII-BamHI DNA fragment; and 20 ng of the primer.
For detection of the 18S rRNA, we used the following 5Ј-end-labeled singlestranded DNA probe: 5Ј-CTGTCAATCCTGTCCGTGTCCG-3Ј, according to the 18S rRNA sequence in GenBank (accession no. X00686, coordinates 1273 to 1294).
Cell infection and virus titration. NA cells or clones derived from them (2 ϫ 10 4 cells per well) were seeded in triplicate in 24-well plates for 24 h. Cells were infected at MOIs of 0.1, 1, and 10 in 250 l of MEEM without serum. After 2 h, the medium was removed and 1 ml of fresh medium with serum was added to every well. Twenty-four hours later, the plates were stored at Ϫ70°C.
For HSV-1 titration, the cells and medium of each well were removed and sonicated. CV-1 cells (1.3 ϫ 10 5 per well) were seeded in 24-well dishes in 0.5 ml of Dulbecco's modified Eagle's medium including 10% FCS and 48 h later were used for titration as described elsewhere (60), with 0.5 mg of human gamma globulin per ml.
For RNA extraction, cell lines NA-neo and NA-LAT#1, 2 ϫ 10 6 cells each, were infected at an MOI of 1 with LAT-negative mutant in 4 ml of MEEM without serum. After 1 h, the medium was removed and 10 ml of fresh medium with serum was added to every plate. Six hours later, the cells were extracted for RNA isolation as described above. The pIE-CAT construct, containing the CAT gene sequence under the control of the HSV-1 ICP0 promoter (from Ϫ585 to ϩ150 [19] ), and the pRSV-CAT construct, which contains the CAT gene under the control of the long terminal repeat promoter of Rous sarcoma virus (23), were kindly provided by D. Latchman, London, United Kingdom. Cells (0.5 ϫ 10 6 ) were transfected with 1.25 and 0.25 g of DNA, respectively, as described before (37). Following transfections, cells were harvested and the protein content was determined by the method of Bradford (7) . Samples equalized for protein content were assayed for CAT activity. The vector pRSV-CAT was used as a control plasmid to correct for differences in transfection efficiencies. This was done in duplicate for each experiment.
Cell viability assay (MTT)
DNA dot blot. Plasmid DNA was extracted from equal amounts of transfected cells by the Hirt procedure (27), and identical volumes were denatured in 0.4 N NaOH-10 mM EDTA for 10 min at 96°C. The samples were then added to the slot blot apparatus, transferred to a GeneScreen Plus membrane (New Research Products), hybridized, and washed according to the manufacturer's instructions. Computerized image analysis and quantitation were performed by a Bio-Imaging analyzer as described for RNA.
RESULTS
Establishing neuronal cell lines that stably express the HSV-1 latency-associated gene(s). In order to examine the effect of the gene(s) expressed during HSV-1 latent infection upon viral replication in neuronal cells and to delineate the DNA sequences which are responsible for any observed effect, we have constructed three vectors. (i) pLAT/ICP0 (Fig. 1C [37]) is a plasmid containing an HSV-1 10.4-kb DNA fragment which includes the entire sequences that are transcriptionally active during latency, under the control of the constitutive IE CMV promoter. This fragment also contains the coding sequences of the ICP0, ␥34.5, ORF P, and ORF O genes. (ii) p⌬prLAT (Fig. 1D ) is a plasmid derived from the pLAT/ICP0 vector by deletion of the CMV and LAP2 (21) promoters. This vector is unable to express the LATs or the mLAT but still contains the coding sequences of ICP0, ␥34.5, ORF P, and ORF O. (iii) pLAT (Fig. 1E ) is a plasmid derived from pLAT/ ICP0 and having deletions of all the sequences downstream from the DNA fragment that transcribes the LATs.
These vectors and pSV 2 neo were stably transfected into the NA neuronal cell line to produce three G418-resistant populations, NA-LAT/ICP0, NA-⌬prLAT, and NA-LAT. Sixteen cell clones were randomly isolated from each population and were examined by RT-PCR and Northern blot analysis for expression of the relevant transcripts. Clones NA-LAT/ ICP0#1 (previously termed NA4 [22]), NA-⌬prLAT#1, and NA-LAT#1, which express these transcripts, were randomly chosen. NA-neo, a negative clone harboring only pSV 2 neo, was selected as a negative control.
The neuronal cell clones were examined for expression of the 2.0-and 1.5-kb LATs by Northern blot analysis ( Fig. 2A) and by RT-PCR (Fig. 2B ). While the 2.0-kb LAT was present at amounts high enough to be easily visualized by Northern blot analysis in NA-LAT#1 and NA-LAT/ICP0#1 cells and latently infected mouse TG ( Fig. 2A , lanes 4, 5, and 2, respectively) and was absent from NA-⌬prLAT#1 and NA-neo cells (lanes 3 and 6, respectively), the 1.5-kb LAT was produced at low levels and was observed on Northern blots only as a faint band and after overexposure of the film (data not shown). This transcript was clearly identified in RNA from latently infected mouse TG (lane 2). However, a DNA band with an expected size of 255 bp, representative of the 1.5-kb LAT (Fig. 1F By Northern blot analysis, clone NA-⌬prLAT#1 was found to produce the ICP0 transcript ( Fig. 2A, lane 3) . As expected, both the 2.7-kb ICP0 transcript and the 2.0-kb LAT were observed in HSV-1-infected CV-1 cells (Fig. 2A, lane 1) .
HSV-1 replication is suppressed in neuronal cell clones that express the LATs. In order to study the effect of the gene(s) expressed during HSV-1 latency on viral replication in neuronal cells, we infected the three neuronal cell clones, NA-LAT/ ICP0#1, NA-⌬prLAT#1, and NA-LAT#1, with HSV-1 (strain F). NA-neo cells were used as a control (Table 1) . Twenty-four hours postinfection, plates were stored at Ϫ70°C. Prior to titration on CV-1 cells, the infected cells together with the medium were sonicated. All experiments were performed in triplicate. Presented are the averaged results of a representative experiment. To ensure that the MOI would be accurate, control plates were subjected to cell quantification by the MTT assay.
At an MOI of 0.1, no HSV-1 replication could be detected in NA-LAT/ICP0#1 and NA-LAT#1 cells (Table 1) . Since titration was performed in 0.25 ml of a total volume of 1 ml, lack of plaques on titration assay is represented as Ͻ4. HSV-1 replication was detectable in NA-neo and NA-⌬prLAT#1 cell clones. At an MOI of 1, HSV-1 replication was markedly suppressed in LAT/ICP0#1 and NA-LAT#1 cells compared to that in NA-neo cells by similar orders of magnitude of about 330-and 220-fold, respectively. The NA-⌬prLAT#1 cells were unable to suppress HSV-1 replication. At an MOI of 10, the suppressive effect of the LATs upon HSV-1 replication was almost completely abolished. Similar results were obtained in repeated experiments, with the same cell clones, and in experiments with three additional cell clones randomly selected from the NA-LAT/ICP0, NA-⌬prLAT, and NA-LAT cell populations (data not shown).
To validate these results, similar infection experiments were carried out with the three neuronal cell populations as well. The parental neuronal NA cells were used as the control. As expected, HSV-1 replication was repressed in the LAT-expressing populations (NA-LAT/ICP0 and NA-LAT) compared to that in the NA-⌬prLAT and NA populations, and the suppressive effect was MOI dependent (data not shown).
Thus, HSV-1 replication was suppressed in NA-LAT/ ICP0#1 cells, which contain the entire DNA sequence transcriptionally active during latency, including the coding sequences for the LATs, mLAT, ICP0, ␥34.5, ORF P, and ORF O. A similar effect was demonstrated with NA-LAT#1 cells, which are capable of expressing only the LATs, suggesting that the observed inhibition of HSV-1 replication is mediated by the LATs and not by the ICP0, ␥34.5, ORF P, or ORF O gene. Indeed, the repressive effect upon HSV-1 replication was not present in NA-⌬prLAT#1 cells, which are incapable of expressing the LATs but express ICP0 and also contain the three genes ␥34.5, ORF P, and ORF O.
The suppressive effect of the LATs upon HSV-1 replication was MOI dependent (Table 1) . At an MOI of 0.1, no viral replication could be detected in NA-LAT/ICP0#1 and NA-LAT#1 cells, compared to that in NA-neo cells, while at an MOI of 1 the differences were 330-and 220-fold, respectively. At an MOI of 10, the suppressive effect was almost completely abolished.
Replication of HSV-1 LAT-negative mutant is suppressed in a neuronal cell clone that expresses the LATs. In order to further substantiate the findings that HSV-1 LATs suppress viral replication in neuronal cell clones, we repeated these experiments in parallel and under similar conditions, with a LAT-negative HSV-1 mutant. We used the FS1001K mutant, in which a 1.1-kb fragment starting from the 5Ј end is deleted from the 2.0-kb LAT coding sequence to abolish all LAT expression (15) .
Twenty-four hours postinfection, virus yield in NA-LAT#1 and NA-neo cells was determined by titration on CV-1 indicator cells. This experiment was performed in triplicate, and the average results are presented in Table 2 . HSV-1 LATnegative mutant replication was suppressed in NA-LAT#1 cells compared to that in the control NA-neo cells. The effect (Fig. 1F) . The DNA probe used was BstEII-BstEII (Fig. 1) . RT was performed with primer P3, and PCR was performed with primers P3 and P2. 
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a HSV-1, produced by the LAT-expressing NA-LAT/ICP0#1 and NA-LAT#1 clones and by the control NA-⌬prLAT#1 and NA-neo clones, was quantitated on CV-1 cells. Since titration was performed on 0.25 ml of a total volume of 1 ml, lack of plaques in the titration assay is represented as Ͻ4. All experiments were performed in triplicate, and the results represent the average calculations. was again MOI dependent, i.e., more pronounced at a low MOI of 0.1, where the inhibition was 160-fold. Similar results were obtained in repeated experiments. These results substantiate the findings that the LATs suppress HSV-1 replication in neuronal cells and indicate that the LAT effect has a transacting component.
ICP0 mRNA levels are suppressed in a neuronal cell line that expresses the LATs. Since HSV-1 replication is dependent on the expression of the viral IE genes, we hypothesized that the LATs may reduce HSV-1 replication in neuronal cells by down-regulating expression of the IE genes. We chose initially to examine the influence of the LATs on ICP0 expression for the following reasons. (i) ICP0 is the first IE gene to be expressed at very early times postinfection (36). (ii) This IE protein is a transactivator which enhances HSV-1 replication during acute infection as well as reactivation from latency (9) and is capable of activating all three kinetic classes of HSV genes (10) . (iii) The sequences of ICP0 mRNA and of the LATs overlap at their 3Ј end (and therefore an antisense mechanism for LAT action has been proposed elsewhere [64] ). (iv) The pLAT/ICP0 vector used in this work (Fig. 1C) includes the entire DNA sequences required for ICP0 expression (46). (v) The LATs have been shown elsewhere to inhibit ICP0 protein synthesis (20) and ICP0-mediated transactivation (16) .
(i) The levels of ICP0 mRNA produced by an HSV-1 LATnegative mutant are suppressed in a neuronal cell line that expresses the LATs. The LAT effect upon ICP0 expression was first examined by infecting LAT-expressing NA-LAT#1 and NA-neo control cells with the LAT-negative mutant at an MOI of 1. RNA was extracted 6 h postinfection, resolved by gel electrophoresis, Northern blotted, and hybridized with the BstEII-BamHI DNA probe specific to both ICP0 mRNA and LATs (Fig. 1B) . ICP0 mRNA was barely expressed in NA-LAT#1 cells (Fig. 3A, lane 1) and was readily identified in NA-neo cells (lane 2). Bio-Imager quantification of ICP0 mRNA suggested a 16-fold inhibition.
To confirm that the identified band was indeed ICP0 mRNA, we repeated this experiment with an ICP0-specific single-stranded DNA probe (Fig. 3B) . As expected, a 2.7-kb RNA band, of the size of ICP0 mRNA, was identified in RNA obtained from NA-neo cells infected with HSV-1 (lane 2) and not in control RNA from uninfected cells (lanes 3 and 4) . The ICP0 mRNA was barely visualized in the HSV-1-infected LAT-expressing NA-LAT#1 cells (lane 1). To validate the finding that equal amounts of RNA were loaded in each lane, we also hybridized the blot with a single-stranded DNA probe specific for the 18S rRNA (Fig. 3E) . Measurement of rRNA levels by Bio-Imager showed a 1.1-fold difference in the amounts of RNA from NA-LAT#1-infected cells compared to that from NA-neo-infected control cells (Fig. 3E, lanes 1 and 2,  respectively) .
These results indicate that expression of HSV-1 LATs in a neuronal cell clone reduces the ICP0 mRNA levels. It also shows that this effect can be mediated in trans.
(ii) LATs reduce ICP0 mRNA levels following transfection of pLAT/ICP0 into NA cells. To rule out the possibility that the LATs interfere with HSV-1 entry into cells, with subsequent reduction of ICP0 mRNA, and to examine whether the LAT effect upon ICP0 mRNA is a direct one, we used a second approach. NA cells were transfected with either pLAT/ICP0, which contains the LAT and ICP0 genes (Fig. 1C) , or with p⌬prLAT, which has deletions of the CMV promoter and of LAP2 (Fig. 1D) and is therefore unable to express the LATs but still expresses ICP0 (Fig. 2) .
RNAs were extracted from NA cells 48 h posttransfection, resolved by gel electrophoresis, Northern blotted, and hybridized with a BstEII-BamHI probe specific to both ICP0 mRNA and the LATs (Fig. 1B) . While ICP0 mRNA was visualized in NA cells transfected with p⌬prLAT (Fig. 4A, lane 3) , no ICP0 mRNA was observed in pLAT/ICP0-transfected NA cells (lane 2). Bio-Imager quantification suggested a difference of at least 58-fold in ICP0 mRNA levels between the NA cells transfected with each of these vectors. As described previously, singlestranded ICP0-specific probe confirmed the identity of the ICP0 mRNA (Fig. 4B) , following rehybridization of the same blot shown in Fig. 4A . To ensure that equal amounts of RNA were loaded in each lane, we also hybridized the blot with the SOD probe (2) (Fig. 4A, bottom) . Measurement of SOD mRNA levels by Bio-Imager showed a 1.4-fold difference in the amounts of RNA from p⌬prLAT-transfected cells compared to that from pLAT/ICP0-transfected cells (Fig. 4A, lanes  3 and 2, respectively) . To quantitate the efficiency of transfection in the NA cells, a Hirt procedure followed by DNA dot blot hybridization was performed. It indicated that similar amounts of p⌬prLAT and pLAT/ICP0 DNAs entered the NA cells (Fig. 4C) .
To investigate whether in the presence of the LATs small amounts of ICP0 mRNA may still be detected, we have applied the much more sensitive technique of RT-PCR followed by Southern blot analysis. The 296-bp DNA fragment representative of the spliced ICP0 mRNA (Fig. 1F) was present in the two respective preparations (Fig. 4D, lanes 4 and 5) . Appropriate controls without RT enzyme in the reaction mixture identified no DNA band (lanes 1 to 3) . This would indicate that, while the LATs suppress ICP0 mRNA, residual levels may still be detected.
In order to confirm that the results of the transfection experiments were not due to interference by the strong CMV promoter in pLAT/ICP0 with the native ICP0 promoter, we cotransfected 2.5 g of pIE-0-CAT (a vector containing the CAT gene under the control of the HSV-1 ICP0 promoter) with increasing amounts (0.5 to 2.5 g) of the CMV promoter cloned in the expression vector pCH2N (37). No effect upon CAT expression from the presence of the CMV promoter was noted in the cotransfected NA cells (data not shown).
Taken together, these results (i) indicate that HSV-1 LATs directly reduce ICP0 mRNA levels in neuronal cells and (ii) rule out the possibility that the findings are the outcome of entry of different viral DNA amounts into the two neuronal cell lines or are an experimental in vitro artifact due to the influence of the CMV promoter upon the ICP0 promoter.
LATs do not reduce ICP0 mRNA levels via repression of the ICP0 promoter. Since HSV-1 LATs substantially reduce the steady-state levels of ICP0 mRNA, we went on to examine (Fig. 1) . (D) Southern blot analysis of RT-PCR products from total RNAs obtained from NA-LAT/ICP0#1, NA-⌬prLAT#1, and NA-neo cells. Lanes 1 and 4, NA-LAT/ICP0#1; lanes 2 and 5, NA-⌬prLAT#1; lanes 3 and 6, NA-neo; lanes 1 to 3, control PCR without RT enzyme in the reaction. RT was performed with primer P11, and PCR was performed with P11 and P10. The probe used is the BstEII-BamHI DNA fragment. The 296-bp DNA is representative of the spliced ICP0 mRNA (Fig. 1F) . their direct effect upon the ICP0 promoter. pIE-0-CAT (19) was transfected into NA-LAT#1 and into NA-neo control cells. CAT activity was determined in duplicate in crude cell extracts (Table 3) . All experiments included a control plasmid, pRSV-CAT, in which the Rous sarcoma virus promoter drives the expression of CAT (23), to correct for differences in transfection efficiency. This control vector was transfected in duplicate in each experiment, and the reported results represent the average.
While the vector pIE-0-CAT expressed CAT in NA-LAT#1 cells at about 3.8-fold-higher levels relative to that in NA-neo cells, the control vector, pRSV-CAT, also expressed about 3.5-fold-higher amounts of CAT in NA-LAT#1 cells relative to that in NA-neo cells. Thus, the difference in the levels of activity of the ICP0 promoter between these two cell lines originated from the difference in transfection efficiencies rather than from any LAT effect on the ICP0 promoter.
The levels of ICP4 and ICP27 mRNA produced by HSV-1 LAT-negative mutant are suppressed in a neuronal cell line that expresses the LATs. Following the observation that ICP0 mRNA was reduced by the LATs, we went on to examine LAT effects upon ICP4 and ICP27 mRNA levels, because these two IE genes are essential for viral replication. Since it was proposed that the LATs affect ICP0 via an antisense mechanism, the effect of the LATs on the expression of other IE genes might shed light upon the LAT action mechanisms.
Measurements of ICP4 and ICP27 mRNA levels were performed in parallel with those of ICP0 mRNA levels, on the RNA samples from NA-LAT#1 and NA-neo cells following infection with HSV-1 LAT-negative mutant at an MOI of 1. RNAs were resolved by gel electrophoresis, Northern blotted, and hybridized with an AflIII-BamHI DNA probe specific for ICP4 mRNA (Fig. 1B) or with the PCR product-specific probe for ICP27 mRNA (see Materials and Methods). Both ICP4 and ICP27 mRNA levels were reduced in the NA-LAT#1 cells compared to the control NA-neo cells (Fig. 3C, lanes 1 and 2,  and 3D, lanes 1 and 2, respectively) . Bio-Imager quantification indicated a difference of about fourfold in ICP4 mRNA levels and about threefold in ICP27 mRNA levels in NA-neo cells compared to that in NA-LAT#1 cells, after correction for different amounts of RNA loaded from NA-LAT#1 and from NA-neo cells (1.1-fold).
These results indicate that the LATs also reduce ICP4 and ICP27 mRNA levels in the neuronal cell line.
DISCUSSION
The LATs suppress viral replication in neuronal cell lines. Our aim in this study was to examine the role of the latencyassociated gene(s) in HSV-1 replication and to map the viral genomic region responsible for any observed effect. Any approach to addressing this question must take into account the fact that, within the sequence(s) of the HSV-1 latency-associated gene(s), other genes such as ␥34.5, ICP0, ORF P, and ORF O and transcripts designated L/STs (69) are located. Therefore, we constructed three different vectors which enabled us to separate the expression of LAT from that of the other genes expressed from this viral genomic region.
Our findings demonstrate that, at an MOI of 0.1, no HSV-1 replication could be detected in the NA-LAT/ICP0#1 neuronal cell clone and that, at an MOI of 1, it was reduced up to 330-fold compared to that in the control NA-neo cells (Table  1 ). However, the other genes located within pLAT/ICP0 may have also affected HSV-1 replication (8, 10, 44, 48, 55) . In order to delineate the viral locus responsible for replication inhibition, we used the two other cell clones, NA-LAT#1 and NA-⌬prLAT#1. Our findings indicate that the suppressive effect upon HSV-1 replication may be mediated by the LATs alone and not by the other genes located downstream from the LAT gene (Table 1) . These results were substantiated by a complementary approach, in which a virus having the LAT gene deleted was applied. We showed that a LAT-negative HSV-1 mutant replicated better in the control NA-neo cells than in NA-LAT#1, the latter cell line complementing in trans the lack of LATs (Table 2) . In this experiment, we conclusively indicate that the LATs may act via a trans mechanism.
In comparing replication abilities of the LAT-negative mutant and HSV-1 in the various NA cell clones, two observations should be noted: (i) the LAT-negative mutant replicated better than HSV-1 (in 10-to 100-fold-higher titers) in NA-neo cells (Tables 1 and 2) , and (ii) the suppressive effect upon viral replication was less pronounced with the LAT-negative mutant. These findings may suggest that the suppressive effect upon HSV-1 replication is dependent upon the cellular amounts of the LATs and that it has also a cis-acting component.
The impact of the LATs upon HSV-1 replication was MOI dependent, being more pronounced at lower MOIs. This probably reflects a biologically important mechanism, since the viral titer that is obtained during acute infection in mice TG suggests a low viral load (reference 61 and our unpublished data). A similar MOI-dependent effect was demonstrated for the neuronal transcription factors Oct-2 (35) and N-Oct-3 (25), which suppressed viral replication in neuronal cells. It seems, therefore, that cellular and viral factors, which act to reduce HSV-1 replication in neuronal cells, are most effective at low viral loads, which are indeed present during the in vivo infection.
The LATs reduce ICP0, ICP4, and ICP27 mRNA levels in neuronal cell clones. To study the mechanism responsible for viral replication suppression by the LATs, we chose first to examine the influence of LATs on ICP0 gene expression. Using an HSV-1 LAT-negative mutant for infection of LATexpressing neuronal cell lines, we demonstrated that the LATs reduce ICP0 mRNA steady-state levels at an MOI of 1 (Fig.  3A) , an HSV-1 MOI that also showed effective suppression of viral replication in these cells (Tables 1 and 2 ). These findings are in accordance with studies indicating that ICP0-negative mutants grow poorly at low MOIs (9, 10, 51) . A transfection experiment with a plasmid coding for both ICP0 and the LATs gave identical results (Fig. 4A) , indicating that the LAT effect upon ICP0 steady-state mRNA levels was most probably mediated directly and not through other viral gene products. The LAT effect upon ICP0 mRNA steady-state levels is not the result of ICP0 promoter suppression. This conclusion is based on the observation that the LATs were unable to reduce CAT expression driven by the ICP0 promoter, following transfection of pIE-0-CAT into NA-LAT#1, the LAT-expressing neuronal cell line (Table 3) .
HSV-1 infection experiments have also shown that the LATs reduce the steady-state mRNA levels of two other IE genes, ICP4 and ICP27 (Fig. 3C and D) . However, while the LATs suppressed ICP0 mRNA by 16-fold, they reduced ICP4 and ICP27 mRNA by only 3-to 4-fold.
How do the LATs act upon HSV-1 IE genes? The LAT sequence overlaps the 3Ј end of the ICP0 transcript and therefore may regulate its turnover by an antisense mechanism (16, 64) . Nevertheless, an antisense mechanism for ICP0 inhibition was not supported by a genetic approach that used an HSV mutant with deletion of the LAT-ICP0 overlapping sequences (43). Our present finding that the LATs act also upon ICP4 and ICP27 does not resolve this question. It might be that the LATs act directly and in a similar fashion upon all three IE genes, making the antisense hypothesis for LAT action unlikely. Alternatively, the reduced ICP4 and ICP27 mRNA levels in the presence of the LATs might be a consequence of reduced ICP0 mRNA levels. Indeed, it was shown that, in the absence of structural viral proteins such as Vmw65 (10) and at a low MOI, ICP0 can activate the expression of ICP4 and ICP27 genes (10, 30, 36) . Further experiments are in progress to address the mechanism of action of the LATs upon ICP0, ICP4, and ICP27.
The possible mechanism(s) of LAT action upon HSV-1 reactivation. In general, the consistent phenotype of LAT-negative mutants is defective reactivation (4, 6, 26, 42, 53, 61, 67) . However, no evidence to prove a direct role for LATs in reactivation has so far been presented. The other possibility is that this gene(s) functions to promote the ability of HSV-1 to establish latent infection in neurons, increasing the pool of latently infected cells and indirectly improving reactivation ability (3, 53) . This is supported by the recent observation that HSV-1 reactivation efficacy correlated with its ability to establish latent infection in a high percentage of neurons (66) .
Our findings indicate that HSV-1 LATs suppress viral replication in neuronal cell lines in parallel with reduction of ICP0, ICP4, and ICP27 mRNA levels. By reducing these IE gene mRNA levels, the LATs may keep HSV-1 replication below levels which culminate in neuronal cell destruction and thus facilitate the establishment of viral latent infection. This hypothesis is in accordance with the observations derived from studies with latently infected mouse DRG tissues of increased numbers (i) of latently infected cells with a LAT-positive virus compared to those with LAT-negative mutants (38, 52, 53, 66) and (ii) of neurons expressing ICP4 and ICP27 during LATnegative mutant infection compared to wild-type virus (11, 18) .
Why would the LATs suppress IE genes and hence replication during primary infection but not during reactivation? Partial explanations may be based on the findings that the cellular amounts of LATs decrease during reactivation (57) and/or that, following a reactivation trigger, early genes are expressed first and prior to IE gene expression, bypassing the LAT blocking effect upon IE genes (65) .
However, the LATs may not be the only factors involved in the establishment of latency, as viruses lacking LATs are still capable of establishing latent infection (28, 29, 54, 61). ORF P and ORF O together can block the expression of regulatory proteins essential for viral replication (8, 48) , and at least two neuronal transcription factors may promote the establishment of latency via blockage of the transactivating action of Vmw65 (25, 35).
Further investigation of the mode of LAT action upon HSV-1 IE genes may now be performed in the cell lines constructed and characterized in this work.
